World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
38188
World Ranking
13899
National Ranking
65

Alv A. Dahl publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alv A. Dahl sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 383 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alv A. Dahl D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alv A. Dahl sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Alv A. Dahl is affiliated with the University of Oslo in Norway and has made significant contributions in the field of medicine. Their research primarily focuses on oncology, pediatrics, perinatology and child health, pulmonary and respiratory medicine, sociology and political science, and psychiatry and mental health.

The scientific topics Dahl has investigated include cancer survivorship and care, childhood cancer survivors' quality of life, family support in illness, cancer-related cognitive impairment studies, sexual function and dysfunction studies, prostate cancer diagnosis and treatment, and testicular diseases and treatments.

Among Dahl's recent publications are:

  • Sexual activity and functioning in long-term breast cancer survivors; exploring associated factors in a nationwide survey (2022, Breast Cancer Research and Treatment)
  • Norwegian reference data on the Fatigue Questionnaire and the Patient Health Questionnaire-9 and their interrelationship (2020, Annals of General Psychiatry)
  • Work status changes and associated factors in a nationwide sample of Norwegian long-term breast cancer survivors (2022, Journal of Cancer Survivorship)
  • Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study (2020, Cancer Epidemiology)
  • Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective (2023, Annals of Oncology)

Dahl has collaborated frequently with colleagues including Cecilie E. Kiserud, Sophie D. Fosså, Kristin V. Reinertsen, Tor Åge Myklebust, and Kathrine F. Vandraas.

Key venues where Dahl's work has been published include:

  • Journal of Cancer Survivorship
  • Breast Cancer Research and Treatment
  • Cancers
  • Acta Obstetricia Et Gynecologica Scandinavica
  • Scandinavian Journal of Urology

Best Publications

  • The validity of the Hospital Anxiety and Depression Scale: An updated literature review

    Ingvar Bjelland;Alv A Dahl;Tone Tangen Haug;Dag Neckelmann

  • The International Personality Disorder Examination: The World Health Organization/Alcohol, Drug Abuse, and Mental Health Administration International Pilot Study of Personality Disorders

    Armand W. Loranger;Norman Sartorius;Antonio Andreoli;Peter Berger

  • Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population.

    Arnstein Mykletun;Eystein Stordal;Alv A. Dahl

  • Chronic insomnia as a risk factor for developing anxiety and depression.

    Dag Neckelmann;Arnstein Mykletun;Arnstein Mykletun;Alv A. Dahl

  • Does a higher educational level protect against anxiety and depression? The HUNT study.

    Ingvar Bjelland;Steinar Krokstad;Arnstein Mykletun;Alv A. Dahl

  • The hospital anxiety and depression rating scale: A cross-sectional study of psychometrics and case finding abilities in general practice

    Ingrid Olssøn;Arnstein Mykletun;Arnstein Mykletun;Alv A Dahl

  • The association between anxiety, depression, and somatic symptoms in a large population: The HUNT-II study

    Tone Tangen Haug;Arnstein Mykletun;Alv A. Dahl

  • Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: The Norwegian HUNT 2 study

    Bjørn Hildrum;Bjørn Hildrum;Arnstein Mykletun;Torstein Nielsen Hole;Kristian Midthjell

  • Depression and anxiety disorders associated with headache frequency. The Nord-Trøndelag Health Study.

    John Anker Zwart;G. Dyb;G. Dyb;K. Hagen;K. J. Ødegård

  • Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase

    E. K. Grov;A. A. Dahl;T. Moum;S. D. Fosså

  • Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire

    Jon Skarstein;Nina Aass;Sophie D Fosså;Eva Skovlund

  • Depression and Diabetes: A large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes

    Anne Engum;Arnstein Mykletun;Kristian Midthjell;Are Holen

  • Testicular Cancer Survivorship: Research Strategies and Recommendations

    Lois B. Travis;Clair Beard;James M. Allan;Alv A. Dahl

  • Testing the Job Demand-Control-Support model with anxiety and depression as outcomes: the Hordaland Health Study.

    Bjarte Sanne;Arnstein Mykletun;Alv A. Dahl;Bente E. Moen

  • Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

    J Beyer;P Albers;R Altena;J Aparicio

  • Depression in relation to age and gender in the general population: the Nord-Trøndelag Health Study (HUNT).

    E. Stordal;M. Bjartveit Krüger;N. H. Dahl;Ø. Krüger

  • A Population-Based Cohort Study of the Effect of Common Mental Disorders on Disability Pension Awards

    Arnstein Mykletun;Simon Overland;Alv A. Dahl;Steinar Krokstad

  • The Swedish Demand-Control-Support Questionnaire (DCSQ): factor structure, item analyses, and internal consistency in a large population.

    Bjarte Sanne;Steffen Torp;Arnstein Mykletun;Alv A. Dahl

  • Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

    Hege S. Haugnes;George J. Bosl;Hink Boer;Jourik A. Gietema

  • Fatigue, Anxiety, and Depression in Long-Term Survivors of Testicular Cancer

    Sophie D. Fosså;Alv A. Dahl;Jon H. Loge

Frequent Co-Authors

Sophie D. Fosså
Sophie D. Fosså Oslo University Hospital
Arnstein Mykletun
Arnstein Mykletun Norwegian Institute of Public Health
Roy M. Bremnes
Roy M. Bremnes University of Tromsø - The Arctic University of Norway
Claes G. Tropé
Claes G. Tropé University of Oslo
Egil W. Martinsen
Egil W. Martinsen University of Oslo
Ted Reichborn-Kjennerud
Ted Reichborn-Kjennerud University of Oslo
Jan Haavik
Jan Haavik University of Bergen
Robert Murison
Robert Murison University of Bergen
Ottar Bjerkeset
Ottar Bjerkeset Nord University
Stein Andersson
Stein Andersson University of Oslo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees can open new doors for those interested in the medical field but seeking alternative or flexible educational paths. Programs such as online nutrition degree programs allow students to study how diet impacts health, leading to careers in public health, wellness coaching, or clinical nutrition.

For those interested in healthcare administration, accredited mha programs prepare graduates for leadership roles in hospitals, clinics, and insurance organizations. Nursing professionals can also enhance their qualifications through online rn to bsn programs without clinical requirements, which simplify the path for working nurses to earn a bachelor’s degree.

Ambitious nurses seeking the highest clinical education may consider the fastest online dnp programs, enabling doctoral-level study in a condensed timeframe. These diverse online pathways support a variety of healthcare careers, offering flexibility for working professionals and those balancing other commitments.

Best Scientists Citing Alv A. Dahl

Trending Scientists

Recently Published Articles